Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | PLA2G6 | O60733 | 2/20 | 0.34 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23914287 | 0.87 | SLC6A4 (0.51) | SLC6A4POLB | |
| SCHEMBL23913804 | 0.87 | SLC6A4 (0.51) | SLC6A4POLB | |
| SCHEMBL23914311 | 0.86 | CTRB1 (0.35) | CTRB1SLC6A4MEN1KMT2APLA2G6 | |
| SCHEMBL23914312 | 0.86 | CTRB1 (0.35) | CTRB1SLC6A4MEN1KMT2APLA2G6 | |
| SCHEMBL23913813 | 0.83 | SLC6A4 (0.53) | SLC6A4ALDH1A1ALOX12 | |
| SCHEMBL23914260 | 0.79 | HDAC4 (0.39) | ALDH1A1MEN1KMT2A | |
| SCHEMBL23914069 | 0.76 | ALDH1A1 (0.41) | SLC6A4ALDH1A1MEN1KMT2APOLB | |
| SCHEMBL23914420 | 0.76 | ALDH1A1 (0.41) | SLC6A4ALDH1A1MEN1KMT2APOLB | |
| SCHEMBL23914073 | 0.76 | CTRB1 (0.37) | CTRB1ALDH1A1MEN1KMT2APLA2G6 | |
| SCHEMBL23914401 | 0.74 | ALDH1A1 (0.35) | SLC6A4ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | MIF, LTA, MGAM | CTRB1 4601/4885SLC6A4 4444/4885ALDH1A1 2164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.